GLP-1RA as new treatment option on the horizon for obesity - PACE-CME

GLPRA as new treatment option on the horizon for obesity

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

No role of Lp(a) in thrombosis
No role of Lp(a) in thrombosis
EAS 2022
No role of Lp(a) in thrombosis
- Prof. Alberico Catapano, PhD
How to overcome the excess ASCVD risk conferred by Lp(a)?
How to overcome the excess ASCVD risk conferred by Lp(a)?
EAS 2022
How to overcome the excess ASCVD risk conferred by Lp(a)?
- Prof. Alberico Catapano, PhD
Welcome to the EAS 2022 congress
Welcome to the EAS 2022 congress
EAS 2022
Welcome to the EAS 2022 congress
- Prof Kausik Ray
Targeting the ANGPTL3 pathway for lowering TG-rich lipoproteins
Targeting the ANGPTL3 pathway for lowering TG-rich lipoproteins
EAS 2022
Targeting the ANGPTL3 pathway for lowering TG-rich lipoproteins
- Nicholas Marston, MD